← Back to headlines
Truist Lowers Price Target for Alnylam Pharmaceuticals (ALNY)
Truist has adjusted its price target for Alnylam Pharmaceuticals (ALNY), lowering it from $515 to $505.
20 Apr, 21:31 — 20 Apr, 21:31
Sources
Showing 1 of 1 sources
Truist has adjusted its price target for Alnylam Pharmaceuticals (ALNY), lowering it from $515 to $505.